Emyria
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
661 d2, Leederville, Western Australia, ...Phone Number
+61 865592800Website
www.emyria.comRevenue
<$5 MillionStock Symbol
EMDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Emyria
Founded in 2018 and headquartered in Leederville, Australia, Emyria is a clinical-stage biotech company, engaged in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program.Explore more
Emyria Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emyria your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Emyria, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Emyria is spiking on competitors!
Funding: Get notified immidiatlly once Emyria has new funding data
Product Launch: Get notified when Emyria launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Emyria
Click to see if Emyria had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Emyria has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Emyria recently announced quarterly report
Recommended Actions
Find VP level buyers at Emyria
Find 2 more new buyers
Compare Similar Companies to Emyria
Compare insights from companies similar to Emyria, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Emyria is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Emyria is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Emyria.
Emyria financials insights
Gather financial insights about Emyria, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Share Placement
$2.5M
Emyria Tech Stack
A closer look at the technologies used by Emyria
See more technologies
Emyria News & Media
Emyria announces key leadership changes - Biotech Dispatch
Emyria (ASX:EMD) has announced leadership changes designed to position it to meet anticipated growth in demand for its unique care programs and new forms of therapy.Favourable Signals For Emyria: Numerous Insiders Acquired Stock
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...Emyria Slides As Insider Purchases Lose Another AU$300k
Insiders who bought AU$750.8k worth of Emyria Limited's ( ASX:EMD ) stock at an average buy price of AU$0.087 over the...Emyria Full Year 2023 Earnings: AU$0.018 loss per share (vs AU$0.027 loss in FY 2022)
Emyria ( ASX:EMD ) Full Year 2023 Results Key Financial Results Revenue: AU$1.59m (down 13% from FY 2022). Net loss...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Emyria
Sign Up For FreeTo access detailed company insights
Founded in 2018 and headquartered in Leederville, Australia, Emyria is a clinical-stage biotech company, engaged in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program.... Read More
